Small-Cap Biopharma Stock

Analysts Say This Small-Cap Biopharmaceutical Stock Is A Buy

by Alex Clarke
May 5, 2021

The small-cap biopharmaceutical stock featured in today’s article is a Buy according to the consensus among analysts, who see upside potential of nearly 200% from current levels.